<DOC>
	<DOCNO>NCT01029444</DOCNO>
	<brief_summary>The purpose study determine restore normal metabolic function patient either type I type II diabetes improve impact consequence diabetic complication specifically wide swing blood glucose erratic control even optimal condition . Patients treat week pulsatile intravenous insulin therapy mimic normal insulin secretion . Blood sugar diary laboratory test include quarterly Hemoglobin A1c level monitor measure progress outcome .</brief_summary>
	<brief_title>Effects Pulsed Intravenous ( IV ) Insulin Brittle Uncontrolled Diabetes</brief_title>
	<detailed_description>It know glucose metabolic pathway ( glycolysis ) primary fuel generator brain nerve tissue , heart vascular tissue , eye , kidney liver Deficient metabolic state see glucose metabolism diabetic lead sequela . These damaging effect exacerbate alter cellular metabolite , specifically increase catabolic decrease anabolic factor . It show past twenty year normalization metabolism diabetic patient accomplish mimic normal endogenous insulin pattern ( i.e. , pulse ) . Pulsatile intravenous insulin infusion demonstrate stabilize erratic wide swing blood glucose level overall stabilization hyperglycemic hypoglycemic event Type 1 diabetic patient . This study establish evaluate effect provide pulsatile intravenous insulin therapy type 1 type 2 diabetes determine effect improve diabetic control patient high blood glucose level spite multiple insulin injection wide swing blood sugar despite good control . The RQ determine use metabolic cart . Individuals breathe mask 3-5 minute rest period 30 minute . The ratio exhale volume CO2 inhale volume O2 determine RQ . The physiologic range 0.7 to1.3 . Individuals use fat primary fuel ratio 0.7 , protein mixed fuel 0.8-0.9 carbohydrate 0.9-1.0 . Those take excessive calorie RQ 's high 1.05 . The RQ follow serially do pulsatile IV insulin treatment , 3 successive session single treatment day . The amount intravenous insulin oral glucose give determine RQ change previous session.pulsatile IV insulin therapy encourage glucose metabolism diabetic normalize multiple organ , especially muscle , retina , liver , kidney nerve ending . The process fundamentally require administration high dose insulin pulse similar find non diabetic human pancreas surround portal circulation . Oral carbohydrate give simultaneously augment process prevent hypoglycemia . The process monitor frequent glucose level respiratory quotient ( RQ ) . RQ measure metabolic cart determines ratio VCO2/ VO2 . This ratio specific fuel use one time body . The glucose level monitor keep glucose level appropriate RQ determines need readjust infusion protocol patient subsequent insulin infusion sessions.Patient evaluate post session discharge stable . Frequent monitoring RQ necessary level change rapidly , depend fuel utilize body . Pulsatile IV insulin therapy shift metabolism primarily fatty acid metabolism primarily glucose metabolism . This shift reflect increase respiratory quotient . However rest period RQ may fall back low level . Therefore RQ 's do begin end insulin infusion session 1 hour order appropriately monitor adjust insulin carbohydrate load reach optimal activation session</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>The researcher include 300 patient male female age 18 85 diagnose type 1 type 2 diabetes mellitus . Self report diagnosed significant complication result diabetes . Taking oral agent and/or insulin diabetic control . Under Endocrinologists supervision diabetes management . Endocrinologist must assess approve patient participation study . Ability swallow without difficulty . Ability commit weekly time requirement associate study . Other cause complication related diabetes . Lack intravenous access . Pregnancy . Alcohol abuse , drug addiction use illegal drug . Positive HIV . Inability breathe machine respiratory quotient .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Pulsatile intravenous insulin</keyword>
	<keyword>Oral carbohydrate loading</keyword>
	<keyword>Respiratory Quotients</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Hyperglycemia</keyword>
	<keyword>Diabetes Mellitus , complication</keyword>
</DOC>